Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-03-25
2008-03-25
Duffy, Patricia A. (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388800, C530S389100, C530S389700, C530S391300
Reexamination Certificate
active
10127851
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6569662 (2003-05-01), Tang et al.
patent: WO 99/63088 (1999-12-01), None
Hu et al. (2003, Journal of Proteome Research 2:405-412).
Haynes et al. (1998, Electrophoresis 19:1862-1871).
Pennica et al (Proc. Nal. Acad. Sci, 95:14717-14722, 1998).
Konopka et al (PNAS, 83:4049-52, 1986).
Gokman-Polar et al (Cancer Research 61:1375-1381, 2001).
Genes IV (1997) Ch 29 847-848 Lewn.
Anderson et al , Electrophoresis, 18:533-537, 1997.
Chen et al (Molecular and Cellular Proteomics, 1:304-313, Apr. 2002).
Bork et al Genome Research, 10:398-400, 2000.
Lian et al (Blood, 98:513-524, 2001).
Fessler et al (J. Biol. Chem., 277:31291-31302, 2002).
Greenbaum et al (Genome Biology, 4:117.1-117.8, 2003).
Saito-Hisaminato et al (DNA Res., 9:35, 2002).
Allman (Blood. Jun. 15, 1996;87412):5257-68).
Gronborg et al (Molecular and Cellular Proteomics, 5(1):157-171, 2006).
Najaraja, Oncogene, 25:2328-2338, 2006.
Waghray, 2001 Proteomics 1:1327-1338, 2001.
Sagynaliev (Proteomics, 5(12):3066-3078, 2005).
Lilley et al in “Proteomics” Molecular Biology in Cellular Pathology, (2003) England: John Wiley & Sons, p. 351.
Wildsmith et al in “Gene Expression Analysis Using Microarrays” Molecular Biology in Cellular Pathology, (2003) England: John J Wiley & Sons, pp. 269-286.
Bork et al., Genome Res 398-400, 2000.
Madoz-Gurpide et al (Adv. Exp. Med. Biol. 532:51-58, 2003).
Celis et al. FEBS Letters, 480:2-16, 2000.
Lee et al. (Proc. Natl. Acad., USA, 97(18):9834-9839, 2000).
King et al. (JAMA, 286(18):2280-2288, 2006).
Klein et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Dayhoff, Accession No. P—AAB65259, WO 200073454-A1, Pub Date: Dec. 7, 2000, A. J. Ashkenazi, et al.
Dayhoff, Accession No. P—AAU12403, WO 200140466-A2, Pub Date: Jun. 7, 2001, K. P. Baker, et al.
Dayhoff, Accession No. P—AAY66736, WO 9963088-A2, Pub Date: Dec. 9, 1999, K. Baker, et al.
Dayhoff, Accession No. P—AAB24422, WO 200032221-A2, Pub Date: Jun. 8, 2000, Avi J. Ashkenazi, et al.
Dayhoff, Accession No. P—AAG75607, WO 200122920-A2, Pub Date: Apr. 5, 2001, S M. Ruben, et al.
Dayhoff, Accession No. P—AAM00989, WO 200153453-A2, Pub Date: Jul. 26, 2001, J. E. Ford, et al.
Dayhoff, Accession No. P—AAM00939, WO 200153453-A2, Pub Date: Jul. 26, 2001, J. E. Ford et al.
Dayhoff, Accession No. AAK37778.1, Direct Submission, Submitted: Mar. 20, 2001, A Hattori, et al.
Dayhoff, Accession No. AAK37777.1, Direct Submission, Submitted: Mar. 20, 2001, A. Hattori, et al.
Dayhoff, Accession No. AAF07395.1, Direct Submission, Submitted: Nov. 12, 1998, A. Hattori, et al.
Dayhoff, Accession No. P—AAU07829, WO 200164856-A2, Pub Date: Sep. 7, 2001, S. Levine.
Dayhoff, Accession No. AAF34664.1, Direct Submission, Submitted: Jan. 7, 2000, X. Cui, et al.
Dayhoff, Accession No. NP—057526.1, J Biochem. 125 (5) pp. 931-938 (1999), A. Hattori, et al.
Dayhoff, Accession No. AAF20384.1, Direct Submission, Submitted: Sep. 4, 1999, L. Schomburg.
Dayhoff, Accession No. P—AAB65007, WO 200075375-A1, Pub Date: Dec. 14, 2000, S. M. Ruben et al.
Dayhoff, Accession No. ART1—HUMAN, Direct Submission, Submitted: Sep. 1999, L. Schomburg.
Dayhoff, Accession No. BAA25451.1, Direct Submission, Submitted: Feb. 13, 1998, O. Ohara et al.
GenBank, Accession No. P—AAS21475, WO 200140466-A2, Pub Date: Jun. 7, 2001, K. P. Baker, et al.
GenBank, Accession No. P—AAF44228, WO 200073454-A1, Pub Date: Dec. 7, 2000, A. J. Ashkenazi, et al.
GenBank, Accession No. P—AAZ65082, WO 9963088-A2, Pub Date: Dec. 9, 1999, K. Baker, et al.
GenBank, Accession No. P—AAA77665, WO 200032221-A2, Pub Date: Jun. 8, 2000, A. J. Ashkenazi, et al.
GenBank, Accession No. P—AAH35012, WO 200122920-A2, Pub Date: Apr. 5, 2001, S. M. Ruben, et al.
GenBank, Accession No. P—AAH81799, WO 200157058-A2, Pub Date: Aug. 9, 2001, A. Rosenthal, et al.
GenBank, Accession No. AX210666, WO 0157058-A, Pub Date: Aug, 9, 2001 A. Rosenthal, et al.
GenBank, Accession No. AF106037, Direct Submission, Submitted: Nov. 12, 1998, A. Hattori, et al.
GenBank, Accession No. P—AAH90058, WO 200153453-A2, Pub Date: Jul. 26, 2001, J. E. Ford, et al.
GenBank, Accession No. P—AAS09227, WO 200164856-A2, Pub Date: Sep. 7, 2001, S. Levine.
GenBank, Accession No. AX236947, WO 0164856-A, Pub Date: Sep. 7, 2001, S. Levine.
GenBank, Accession No. AF222340, Direct Submission, Submitted Jan. 7, 2000, S. J. Levine.
GenBank, Accession No. NM—016442, J. Biochem. 125 (5), pp. 931-938 (1999), A. Hattori et al.
GenBank, Accession No. AF183569, Direct Submission, Submitted: Sep. 4, 1999, L. Schomburg.
GenBank, Accession No. P—AAF24165, WO 200075375-A1, Pub Date: Dec. 14, 2000, S. Ruben, et al.
GenBank, Accession No. P—AAH90108, WO 200153453-A2, Pub Date: Jul. 26, 2001, J. E. Ford, et al.
GenBank, Accession No. AY028807, Direct Submission, Submitted: Mar. 20, 2001, A. Hattori, et al.
GenBank, Accession No. AY028806, Direct Submission, Submitted: Mar. 20, 2001, A. Hattori, et al.
GenBank, Accession No. AB011097, Direct Submission, Submitted: Feb. 13, 1998, O. Ohara, et al.
Quackenbush, John, “Microarray Data Normalization and Transformation”, Nature Genetics Supplement, vol. 32, pp. 496-501, Dec. 2002.
Abe, N., et al., “An Increased High-Mobility Group A2 Expression Level is Associated with malignant Phenotype in Pancreatic Exocrine Tissue,”Br J Cancer—89(11):2104- (2003) Abstract.
Ando, M., et al., “Selective Apoptosis of Natural Killer-Cell Tumours by I-Asparaginase,”Br J Haematol.,—130(6):860- (2005) Abstract.
Aust, G., et al., “Human Thyroid Carcinoma Cell Lines and Normal Thyrocytes: Expression and Regulation of Matrix Metalloproteinase Inhibitor-1 Messenger-RNA and Protein,”Thyroid—7(5):713- (1997) Abstract.
Barnes, V.L., et al., “Expression of Embryonic Fibronectin Isoform EIIIA Parallels Alpha-Smooth Muscle Actin in Maturing and Diseased Kidney,”J Histochem Cytochem.—47(6):787- (1999) Abstract.
Bea, S., et al., “BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphonas,”Cancer Res.—61(6):2409- (2001) Abstract.
Blaschke, V., et al., “Rapid Quantitation of Proinflammatory and Chemoattractant Cytokine Expression in Small Tissue Samples and Monocyte-Derived Dendritic Cells: Validation of a New Real-Time RT-PCR Technology,”J Immunol Methods.—246(1-2):79- (2000) Abstract.
Buckley, A.R., et al., “Butyrate-Induced Reversal of Dexamethasone Resistance in Autonomouse Rat Nb2 Lymphoma Cells,”Apoptosis.—2(6):518- (1997) Abstract.
Caberlotto, L. et al.,“Alterations in Neuropeptide Y Levels and Y1 Binding Sites in the Flinders Sensitive Line Rats, A Genetic Animal Model of Depression,”Neurosci Lett.—265(3):191- (1999) Abstract.
Caberlotto, L., et al., “Neurokinin 1 Receptor and Relative Abundance of the Short and Long Isoforms in the Human Brain,”Eur J Neurosci.—17(9):1736- (2003) Abstract.
Choi, D., et al., “Characterization of Cyclin D2 Expression in Human Endometrium,”J Soc Gynecol Investig.—9(1):41- (2002) Abstract.
Couvelard, A., et al., “Human Chorionic Gonadotrophin Beta Expression in Malignant Barrett's Oesophagus,”Virchows Arch.—445(3):279- (2004) Abstract.
Dagenais, A., et al., “Downregulation of EnaC
Goddard Audrey
Godowski Paul J.
Gurney Austin L.
Smith Victoria
Wood William I.
Barnes Elizabeth M.
Dreger Ginger R.
Duffy Patricia A.
Genentech Inc.
Kresnak Mark T.
LandOfFree
Antibodies against the PRO1154 polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against the PRO1154 polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against the PRO1154 polypeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3945893